CIS and Central Eastern Europe Injection Lipolysis Topical Products Market, By Area of Application (Abdominal Fat, Thighs Fat, Upper Arm Fat, Facial Fat Deposits, Buttock Fat, Knee Fat, Others), Gender (Female, Male), End User (Ambulatory Surgical Centers (ASCS), Clinics, Hospitals, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Industry Trends and Forecast to 2029
Market Analysis and Insights
CIS and Central Eastern Europe injection lipolysis topical products market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.2% in the forecast period of 2022 to 2029 and is expected to reach USD 19,733.67 thousand by 2029 from USD 10,035.05 thousand in 2021. The increasing burden of obesity and growing awareness of the fat reduction procedures among obese individuals is the major driver that propelled the market's demand in the forecast period.
However, side effects associated with injection lipolysis may hamper the future growth of the CIS and Central Eastern Europe injection lipolysis topical products market. Adoption of strategic alliances like partnerships and acquisitions by key market players act as an opportunity for the growth of the CIS and Central Eastern Europe injection lipolysis topical products market.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019-2014)
|
|
Quantitative Units
|
Revenue in USD Thousand, Pricing in USD
|
|
Segments Covered
|
By Area of Application (Abdominal Fat, Thighs Fat, Upper Arm Fat, Facial Fat Deposits, Buttock Fat, Knee Fat, Others), Gender (Female, Male), End User (Ambulatory Surgical Centers (ASCS), Clinics, Hospitals, Others), Distribution Channel (Direct Tender, Retail Sales, Others)
|
|
Countries Covered
|
Germany, United Kingdom, France, Netherlands, Switzerland, Poland, Belgium, Ireland, Austria, Romania, Czech Republic, Hungary, Slovakia, Luxembourg, Slovenia, Liechtenstein, Rest of Central Europe, Russia, Kazakhstan, Belarus, Croatia, Azerbaijan, Moldova, Armenia, Kyrgyzstan, Ukraine, Serbia, Rest of CIS Countries
|
|
Market Players Covered
|
Abbvie, Leaderma Inc., Marllor Biomedical Srl, Mesosystem, Laboratorio Innoaesthetics, S.L.., and others
|
Market Definition:
Injection lipolysis chemically reduces the number of fat cells around the injection site. The chemical, called deoxycholic acid, results in fat cell disruption and death. This procedure can be done under local anesthesia, which is injected into the treatment area beneath the chin. After the local anesthesia has been injected, a precise amount of medication is injected in a grid pattern that has been pre-marked on the skin beneath the chin. The medication is injected as a single treatment.
Post COVID-19 Impact on CIS and Central Eastern Europe Injection Lipolysis Topical Products Market
COVID-19 has resulted in a substantial increase in demand for medical supplies from healthcare professionals and the general public for precautionary measures. Manufacturers of these items have an opportunity to take advantage of the increased demand for medical supplies by ensuring a steady supply of personal protective equipment on the market. COVID-19 is anticipated to have a big impact on the CIS and Central Eastern Europe injection lipolysis topical products market.
CIS and Central Eastern Europe Injection Lipolysis Topical Products Market Scope and Market Size
CIS and Central Eastern Europe injection lipolysis topical products market is segmented on the basis of area of application, gender, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Area of Application
- Abdominal Fat
- Thighs Fat
- Upper Arm Fat
- Facial Fat Deposits
- Buttock Fat
- Knee Fat
- Others
On the basis of area of application, the CIS and Central Eastern Europe injection lipolysis topical products market is segmented into abdominal fat, thigh fat, upper arm fat, facial fat deposits, buttock fat, knee fat and others.
Gender
- Female
- Male
On the basis of gender, the CIS and Central Eastern Europe injection lipolysis topical products market is segmented into female and male.
End User
- Ambulatory Surgical Centers (ASCS)
- Clinics
- Hospitals
- Others
On the basis of end user, the CIS and Central Eastern Europe injection lipolysis topical products market is segmented into ambulatory surgical centers (ASCS), clinics, hospitals and others.
Distribution Channel
- Direct Tender
- Retail Sales
- Others
On the basis of distribution channel, the CIS and Central Eastern Europe injection lipolysis topical products market is segmented into direct tender, retail sales and others.
CIS and Central Eastern Europe injection Lipolysis Topical Products Market Country Level Analysis
The CIS and Central Eastern Europe injection lipolysis topical products market is analyzed, and market size information is provided by area of application, gender, end user and distribution channel.
The country covered in the CIS and Central Eastern Europe injection lipolysis topical products market report are Germany, United Kingdom, France, Netherlands, Switzerland, Poland, Belgium, Ireland, Austria, Romania, Czech Republic, Hungary, Slovakia, Luxembourg, Slovenia, Liechtenstein, Rest of Central Europe, Russia, Kazakhstan, Belarus, Croatia, Azerbaijan, Moldova, Armenia, Kyrgyzstan, Ukraine, Serbia, Rest of CIS Countries.
Germany will dominate due to technological advancements and adoption of minimally invasive fat reduction procedures.
The country section of the report also provides individual market impacting factors and domestic regulation changes that impact the market's current and future trends. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands impact sales channels. They are also considered while providing forecast analysis of the country data.
CIS and Central Eastern Europe injection lipolysis topical products market also provides a detailed market analysis of every country's growth in the Telehealth industry. Moreover, it provides detailed information regarding Telehealth sales, the impact of regulatory scenarios, and trending parameters regarding the CIS and Central Eastern Europe injection lipolysis topical products market. The data is available for the historical period 2012 to 2020
Competitive Landscape and CIS and Central Eastern Europe Injection Lipolysis Topical Products Market Share Analysis
CIS and Central Eastern Europe injection lipolysis topical products market's competitive landscape provides the competitor's details. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points are only related to the company's focus on the CIS and Central Eastern Europe injection lipolysis topical products market.
- The major companies which are dealing in the CIS and Central Eastern Europe injection lipolysis topical products market are Abbvie, Leaderma Inc., Marllor Biomedical Srl, Mesosystem, Laboratorio Innoaesthetics, S.L.., and others
Strategic alliances like mergers, acquisitions, and agreements by the key market players are further expected to accelerate the growth of the CIS and Central Eastern Europe injection lipolysis topical products market.
For instance,
- In April, AbbVie Inc. announced the launch of SkinMedica Neck Correct Cream, the first clinically proven cream to firm and tighten the look of crepey skin, prevent and reduce the look of sagging, smooth deep lines, and wrinkles, and enhance skin tone evenness. This has increased the company's medical aesthetics product portfolio
Collaboration, product launch, business expansion, award and recognition, joint ventures, and other strategies by the market player are enhancing the company footprints in the CIS and Central Eastern Europe injection lipolysis topical products market, which also provides the benefit to the organization's profit growth.
SKU-